Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 109.20B | 109.20B | 104.60B | 90.64B | 73.59B | 74.15B |
Gross Profit | 17.05B | 16.87B | 16.08B | 13.04B | 12.07B | 11.81B |
EBITDA | 14.01B | 14.01B | 13.63B | 11.75B | 10.11B | 9.97B |
Net Income | 5.95B | 5.94B | 5.89B | 5.37B | 3.87B | 3.70B |
Balance Sheet | ||||||
Total Assets | 115.53B | 115.53B | 106.81B | 100.36B | 89.20B | 84.87B |
Cash, Cash Equivalents and Short-Term Investments | 47.58B | 47.58B | 43.29B | 39.47B | 34.82B | 32.68B |
Total Debt | 215.00M | 215.00M | 105.00M | 1.63B | 1.62B | 1.62B |
Total Liabilities | 23.26B | 23.26B | 20.75B | 21.33B | 17.18B | 17.38B |
Stockholders Equity | 88.92B | 88.92B | 82.98B | 76.11B | 69.69B | 65.00B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.61B | 8.21B | 4.86B | 3.33B | 4.89B |
Operating Cash Flow | 0.00 | 9.84B | 11.92B | 7.77B | 6.03B | 8.38B |
Investing Cash Flow | 0.00 | -4.50B | -2.97B | -2.62B | -2.62B | -2.56B |
Financing Cash Flow | 0.00 | -3.05B | -6.17B | -2.26B | -2.22B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥139.94B | 10.67 | 2.25% | -1.29% | -26.66% | ||
79 Outperform | ¥87.62B | 7.78 | 4.17% | -6.49% | -16.68% | ||
77 Outperform | ¥80.29B | 12.75 | 2.98% | 4.49% | 5.84% | ||
73 Outperform | ¥79.83B | 9.53 | 4.10% | -1.71% | 0.39% | ||
70 Outperform | ¥46.25B | 51.07 | 4.94% | -3.80% | -66.97% | ||
70 Outperform | ¥87.32B | 13.53 | 3.53% | -11.96% | -46.82% | ||
61 Neutral | $17.99B | 12.87 | -3.58% | 2.97% | 1.27% | -14.28% |